Cargando…

Regression patterns of choroidal melanoma: After palladium-103 ((103)Pd) plaque brachytherapy

PURPOSE: To describe the patterns of regression of choroidal melanoma after treatment with plaque brachytherapy. METHODS: Retrospective interventional case series including 170 consecutive patients treated with (103)Pd eye plaque radiation for choroidal melanoma. Outcome measures were changes in tum...

Descripción completa

Detalles Bibliográficos
Autores principales: Maheshwari, Abhilasha, Finger, Paul T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210576/
https://www.ncbi.nlm.nih.gov/pubmed/29788760
http://dx.doi.org/10.1177/1120672118776146
_version_ 1783367147458658304
author Maheshwari, Abhilasha
Finger, Paul T
author_facet Maheshwari, Abhilasha
Finger, Paul T
author_sort Maheshwari, Abhilasha
collection PubMed
description PURPOSE: To describe the patterns of regression of choroidal melanoma after treatment with plaque brachytherapy. METHODS: Retrospective interventional case series including 170 consecutive patients treated with (103)Pd eye plaque radiation for choroidal melanoma. Outcome measures were changes in tumor thickness, surface characteristics, tumor vascularity, ultrasonography, fluorescein angiography, optical coherence tomography, and histopathology. RESULTS: The mean initial tumor thickness was 3.9 mm (median 2.8 mm; range 2–11.3 mm) that decreased to 1.7 mm (median 1.2 mm; range 0–7.1 mm) after plaque brachytherapy. On imaging, tumors were pigmented in 51% (n = 86/170), amelanotic in 10% (n = 17/170), and variably pigmented in 39% (n = 67/170). Tumor pigmentation increased in 64% (n = 106/166), decreased in 18% (n = 30/166), and was unchanged in 18% (n = 30/166). Of the 120 that demonstrated intrinsic vascularity, 10% (n = 12/120) had decreased tumor-related vascularity and 90% (n = 108/120) showed complete resolution. Subretinal fluid was present in 34% (n = 58/170) of eyes at presentation. Of them, 15% (9; n = 9/58) had persistent SRF at last follow-up. On ultrasound imaging, 88% (n = 149/170) tumors presented with low to moderate internal reflectivity of which 61% (n = 91/149) showed increased reflectivity on regression. We noted a crescendo–decrescendo fluctuation in the presence of orange pigment lipofuscin along with complete resolution of drusenoid retinal pigment epithelial detachments. In the entire series of 170 patients, there was 0.5% (1) failure of local control, 2% (4) secondary enucleations, and 6% (10) patients developing metastasis. CONCLUSION: Findings related to choroidal melanoma regression after (103)Pd plaque brachytherapy included decreased intrinsic tumor vascularity, decreased tumor-related subretinal fluid, increased pigmentation, specific changes in orange pigment lipofuscin and resolution of drusenoid retinal pigment epithelial detachments, as well as decreased tumor thickness with an increase in internal reflectivity on ultrasound.
format Online
Article
Text
id pubmed-6210576
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-62105762018-11-21 Regression patterns of choroidal melanoma: After palladium-103 ((103)Pd) plaque brachytherapy Maheshwari, Abhilasha Finger, Paul T Eur J Ophthalmol Original Research Articles PURPOSE: To describe the patterns of regression of choroidal melanoma after treatment with plaque brachytherapy. METHODS: Retrospective interventional case series including 170 consecutive patients treated with (103)Pd eye plaque radiation for choroidal melanoma. Outcome measures were changes in tumor thickness, surface characteristics, tumor vascularity, ultrasonography, fluorescein angiography, optical coherence tomography, and histopathology. RESULTS: The mean initial tumor thickness was 3.9 mm (median 2.8 mm; range 2–11.3 mm) that decreased to 1.7 mm (median 1.2 mm; range 0–7.1 mm) after plaque brachytherapy. On imaging, tumors were pigmented in 51% (n = 86/170), amelanotic in 10% (n = 17/170), and variably pigmented in 39% (n = 67/170). Tumor pigmentation increased in 64% (n = 106/166), decreased in 18% (n = 30/166), and was unchanged in 18% (n = 30/166). Of the 120 that demonstrated intrinsic vascularity, 10% (n = 12/120) had decreased tumor-related vascularity and 90% (n = 108/120) showed complete resolution. Subretinal fluid was present in 34% (n = 58/170) of eyes at presentation. Of them, 15% (9; n = 9/58) had persistent SRF at last follow-up. On ultrasound imaging, 88% (n = 149/170) tumors presented with low to moderate internal reflectivity of which 61% (n = 91/149) showed increased reflectivity on regression. We noted a crescendo–decrescendo fluctuation in the presence of orange pigment lipofuscin along with complete resolution of drusenoid retinal pigment epithelial detachments. In the entire series of 170 patients, there was 0.5% (1) failure of local control, 2% (4) secondary enucleations, and 6% (10) patients developing metastasis. CONCLUSION: Findings related to choroidal melanoma regression after (103)Pd plaque brachytherapy included decreased intrinsic tumor vascularity, decreased tumor-related subretinal fluid, increased pigmentation, specific changes in orange pigment lipofuscin and resolution of drusenoid retinal pigment epithelial detachments, as well as decreased tumor thickness with an increase in internal reflectivity on ultrasound. SAGE Publications 2018-05-22 2018-11 /pmc/articles/PMC6210576/ /pubmed/29788760 http://dx.doi.org/10.1177/1120672118776146 Text en © The Author(s) 2018 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research Articles
Maheshwari, Abhilasha
Finger, Paul T
Regression patterns of choroidal melanoma: After palladium-103 ((103)Pd) plaque brachytherapy
title Regression patterns of choroidal melanoma: After palladium-103 ((103)Pd) plaque brachytherapy
title_full Regression patterns of choroidal melanoma: After palladium-103 ((103)Pd) plaque brachytherapy
title_fullStr Regression patterns of choroidal melanoma: After palladium-103 ((103)Pd) plaque brachytherapy
title_full_unstemmed Regression patterns of choroidal melanoma: After palladium-103 ((103)Pd) plaque brachytherapy
title_short Regression patterns of choroidal melanoma: After palladium-103 ((103)Pd) plaque brachytherapy
title_sort regression patterns of choroidal melanoma: after palladium-103 ((103)pd) plaque brachytherapy
topic Original Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210576/
https://www.ncbi.nlm.nih.gov/pubmed/29788760
http://dx.doi.org/10.1177/1120672118776146
work_keys_str_mv AT maheshwariabhilasha regressionpatternsofchoroidalmelanomaafterpalladium103103pdplaquebrachytherapy
AT fingerpault regressionpatternsofchoroidalmelanomaafterpalladium103103pdplaquebrachytherapy